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Abstract: The 1,6-conjugate addition of nitromethane to 2-
[(1E,3E)-4-arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones was ac-
complished and led mainly to the corresponding -(nitro-
methyl)chromones. (E)-5′-(Nitromethyl)-3′-styryl-[1,1′-biphenyl]-
2-ol and 3′-aryl-2′-nitro-5′-(nitromethyl)spiro[chromane-2,1′-
cyclohexan]-4-one derivatives were also isolated as minor prod-
ucts from tandem processes, which result from the addition of
a second molecule of nitromethane. The nucleophile scope was
investigated with malononitrile, acetylacetone, ethyl cyano-
Introduction
Chromones (or 4H-chromen-4-ones) are a group of oxygen-con-
taining heterocycles with a benzo-γ-pyrone ring and are wide-
spread in nature. Several biological activities have been attrib-
uted to simple chromones and their analogues.[1] Anticancer,[1a]
cytotoxic,[2] antioxidant,[3] anti-inflammatory,[1a,4] antifungal,[5]
and antiviral[1a] activities are often reported. Chromone deriva-
tives are also seen as interesting scaffolds for further functional-
izations, most of which arise from chemical transformations[6]
such as oxidation,[7] condensation,[8] Diels–Alder,[9] and conju-
gate addition reactions.[10]
The conjugate addition of carbon nucleophiles to electron-
deficient alkenes is one of the most important methods avail-
able for carbon–carbon bond-forming reactions.[11] Moreover,
the asymmetric catalysis of such reactions constitutes a power-
ful synthetic tool for the formation of carbon stereocenters,
which are key structural features in the development of new
bioactive compounds.[12] Commonly reported soft carbon nu-
cleophiles such as nitroalkanes,[10a,13] malonates,[10c,14] malono-
nitrile,[10c,13e,15] cyanoacetates,[16] or enamines[17] readily un-
dergo conjugate additions with various substrates such as
chalcones,[13d,15,16b,18] vinyl ketones,[16a] cinnamylideneaceto-
phenones,[13d,13e] and 2-styrylchromones.[10a,10c,11b,17]
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acetate, and diethyl malonate, which gave the expected 1,6-
addition products; in the last case, it was also possible to isolate
a minor product formed through a 1,8-/1,6-addition sequence.
Computational calculations provided a rationale for the experi-
mental reactivity of carbon nucleophiles with 2-[(1E,3E)-4-aryl-
buta-1,3-dien-1-yl]-4H-chromen-4-ones. The further functionali-
zation of some adducts allowed the preparation of new nitro-
gen-containing heterocyclic compounds, such as new styryl-
pyrrolidines and new pyrazole and bis(pyrazole) derivatives.
Although the 1,4-conjugate addition of carbon nucleophiles
has been widely reported, studies involving the analogous 1,6-
addition reactions are less commonly reported. One of the rea-
sons for the underdevelopment in this area seems to be the
presence of several electrophilic sites in extended conjugated
systems and the inherent difficulties with the control of the
regioselectivity.[11] However, there are cases involving extended
conjugated π systems (such as cinnamylideneacetophenones)
in which the regioselectivity could be controlled, and the
1,4-conjugate addition products were obtained exclu-
sively.[13d,13e,19]
Previous work of our group involved the 1,6-conjugate
addition of nitromethane to (E)-2-styrylchromones with 1,8-di-
azabicyclo[5.4.0]undec-7-ene (DBU) as an organocatalyst to
form 2-(2-aryl-3-nitropropyl)chromones in moderate-to-good
yields.[10a] Later, the 1,6-conjugate additions of ethyl malonate
and malononitrile were also reported, and these reactions unex-
pectedly afforded the stereochemically complex pentasubsti-
tuted spirocyclohexanes.[10c] On the basis of this knowledge,
herein, we intend to provide new insights into the reactivity
of the extended 3,2:α,:γ,δ-triunsaturated 2-[(1E,3E)-4-arylbuta-
1,3-dien-1-yl]-4H-chromen-4-one systems in conjugate addition
reactions with several carbon nucleophiles and further func-
tionalizations of the addition products. The presence of a third
unsaturated moiety extends the π system of 2-[(1E,3E)-4-aryl-
buta-1,3-dien-1-yl]-4H-chromen-4-ones relative to that of 2-
styrylchromones and allows the δ position to become a new
site for nucleophilic attack (possible 1,8-conjugate addition, Fig-
ure 1). This feature enables the synthesis of multisubstituted
heterocyclic derivatives with new stereocenters as well as their
further functionalization to give new nitrogen-containing het-
erocyclic compounds.
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Figure 1. Possible sites of conjugate addition to 2-[(1E,3E)-4-arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones. Nu = nucleophile.
Results and Discussion
Nitromethane Conjugate Additions
On the basis of our previous results on the organocatalyzed
(DBU) 1,6-conjugate addition of nitromethane to (E)-2-styryl-
chromones, our first approach involved the reaction of chro-
mone 1c as a model substrate with 20 and 60 mol-% of DBU
under neat conditions at room temperature (Table 1, Entries 1
Table 1. Screening of the conditions for the reaction of chromone 1c with nitromethane.[a]
Entry Base [mol-%] Solvent T [°C] Time Yield of 2c [%][b] Yield of 3c [%][b] Yield of 4c [%][b] Recovered 1c [%][b]
1 DBU (20) neat r.t. 24 h – – – 95
2 DBU (60) neat r.t. 24 h – – – 85
3 DBU (20) neat 65 24 h 41 – – –
4[c] DBU (20) neat 65 24 h 18 – – 62
5 DBU (20) neat 100 24 h 40 – – –
6 DBU (100) neat r.t. 15 min 25 – – 37
7 DBU (100) neat r.t. 30 min 44 13 7 20
8 DBU (100) neat r.t. 1 h 52 18 12 –
9 DBU (100) neat r.t. 4 h 30 30 8 –
10 DBU (100) neat r.t. 24 h 12 22 7 –
11 TBD (100) neat r.t. 6 d – – – 90
12 DBN (100) neat r.t. 2 h 30 – – traces
13 Cs2CO3 (100) neat r.t. 72 h – – – 80
14[d,e] Cs2CO3 (120) MeCN r.t. 96 h – – – 90
15[e] DBU (100) MeCN r.t. 24 h – – – 95
16[e] DBU (100) DMF r.t. 1 h 50 15 11 –
17[e] DBU (20) THF reflux 24 h 10 – – 67
18[e] DBU (20) EtOH reflux 24 h 18 – – 50
19[e] DBU (150) EtOH reflux 5 h 20 – – –
[a] Reaction conditions: chromone 1c (0.1 mmol) in nitromethane (0.4 mL). r.t. = room temperature; TBD = 1,5,7-triazabicyclo[4.4.0]dec-5-ene. [b] Isolated
yields. [c] Addition of 30 mol-% of Sc(OTf)3. [d] Addition of 50 mol-% of tetrabutylammonium bromide (TBAB). [e] Reaction performed with chromone 1c
(0.1 mmol) and nitromethane (0.4 mL) in solvent (0.5 mL).
Scheme 1. DBU-catalyzed conjugate addition reaction of nitromethane to chromones 1a–1d.
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and 2). After 24 h, no reaction had occurred, and 85–95 % of
the starting chromone was recovered. If the reaction was per-
formed at higher temperatures of 65 and 100 °C, 2c was ob-
tained in ca. 40 % yield, and a lower yield was obtained in the
presence of Sc(OTf )3 (OTf = triflate) as a Lewis acid catalyst[9b]
(Table 1, Entries 3–5). The amount of DBU was increased to
100 mol-%, and several reaction times were investigated
(Table 1, Entries 6–10). The best results were obtained for a
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Scheme 2. Proposed mechanism for the formation of 3c.
reaction time of 1 h, and derivative 2c (1,6-addition product)
was obtained as the major product in 52 % yield along with
minor products 3c and 4c in 18 and 12 % yield, respectively
(Scheme 1 and Table 1, Entry 8).
The efficiencies of other organic and inorganic bases were
also evaluated (Table 1, Entries 11–13), but the reaction only
occurred in the presence of 1,5-diazabicyclo[4.3.0]non-5-ene
(DBN), and derivative 2c was obtained in a lower yield (30 %)
than that obtained with DBU. Several solvents were tested at
different temperatures (Table 1, Entries 14–19), and similar re-
sults to those obtained under neat conditions were achieved in
N,N-dimethylformamide (DMF), in which 2c was obtained in
50 % yield together with 3c and 4c in 15 and 11 % yield, respec-
tively (Table 1, Entries 5 and 16).
The 1H NMR spectrum confirmed the structure of 3c and
showed three triplets (J = 1.6 Hz) at δ = 7.44, 7.58, and 7.68 ppm
for 6′-H, 4′-H, and 2′-H, respectively (see Scheme 1 for atom
numbering). Moreover, a singlet corresponding to 2-OH at δ =
5.44 ppm and another singlet corresponding to CH2NO2 at
δ = 5.51 ppm were also observed. Two doublets at δ = 7.00
and 7.15 ppm were assigned to α-H and -H, respectively, in a
trans configuration (3Jα-H,-H 16.3 Hz). The formation of deriva-
tive 3c could be attributed to the Michael addition of a nitro-
methane anion to C-2 of 2c along with chromone ring opening
to give intermediate I. A DBU-catalyzed intramolecular 1,2-addi-
tion leads to intermediate II, which affords intermediate III
upon dehydration, and the elimination of HNO2 affords deriva-
tive 3c (Scheme 2).
The plausible mechanism for the formation of derivative 4c
involves the 1,8-conjugate addition of a nitromethane anion to
C-δ of chromone 1c to afford intermediate IV. Then, the 1,6-
conjugate addition of another nitromethane anion to C- of IV
gives intermediate V, which undergoes a DBU-catalyzed intra-
molecular 1,4-conjugate addition to C-2 to form the spiro-
trisubstituted cyclohexane 4c (Scheme 3). The 1H NMR spec-
trum of 4c showed aliphatic signals corresponding to five pro-
tons (2′-H, 3′-H, 4′-H, 5′-H, and 6′-H). In particular, the doublet
assigned to 2′-H at δ = 4.81 ppm confirms the presence of a
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nitro group at the 2′-position. Moreover, the 13C NMR spectrum
revealed a signal assigned to C-1′ at δ = 78.5 ppm, which is
typical of a spiro carbon atom (see Scheme 1 for atom number-
ing).
Scheme 3. Proposed mechanism for the formation of 4c.
At this point, the reaction proceeded smoothly in neat condi-
tions or in DMF with 100 mol-% of DBU, but we were not able
to control the regioselectivity. To handle this drawback, we lim-
ited the available amount of nitromethane in the reaction mix-
ture to 1 equiv.; derivative 2c was isolated in 25 % yield, and
31 % of the starting material was recovered (Table 2, Entry 1).
Table 2. Influence of the amount of nitromethane in the reaction with
chromone 1c.[a]
Entry MeNO2 Time Yield of 2c Recovered 1c
[equiv.] [h] [%][b] [%][b]
1 1 1 25 31
2 1 8 6 25
3 3 4 13 21
4 5 2 45 traces
[a] Reaction conditions: chromone 1c (0.1 mmol) in DMF (0.5 mL) with
100 mol-% of DBU. [b] Isolated yields.
Full Paper
A longer reaction time resulted in a lower yield of 2c (Table 2,
Entry 2). In both reactions, 3c and 4c were not detected; there-
fore, 2c may undergo degradation as the reaction proceeds.
Moreover, the recovery of a significant amount of the starting
chromone suggests that more nitromethane is needed to ob-
tain complete reactions. Two experiments were performed with
3 and 5 equiv. of nitromethane, and only 2c was isolated in 13
and 45 % yield, respectively (Table 2, Entries 3 and 4).
The reaction proceeded more quickly and with less degrada-
tion with 5 equiv. of nitromethane. The global yield (2c) only
reached 45 %, whereas the global yield (2c + 3c + 4c) reached
82 and 76 % in neat conditions or DMF with a large excess of
nitromethane, respectively. With the optimized neat conditions
in hand (Table 1, Entry 8) we explored the reactivities of
chromones 1a, 1b, and 1d (Scheme 1 and Table 3). Products
2a–2d were obtained in yields of 38–52 %, along with 3a–3d
in 3–18 % and 4a–4d in 6–12 % yields.
Table 3. Nitromethane conjugate addition reaction to chromones 1a–1d.[a]
Entry R Yield of 2 Yield of 3 Yield of 4
[%][b] [%][b] [%][b]
1 H 40 (2a) 7 (3a) 6 (4a)
2 Cl 38 (2b) 15 (3b) 10 (4b)
3 OMe 52 (2c) 18 (3c) 12 (4c)
4 Me 40 (2d) 3 (3d) 8 (4d)
[a] Reactions conditions: chromones 1a–1d (0.1 mmol) and DBU (0.1 mmol)
in nitromethane (0.4 mL) at room temperature for 1 h. [b] Isolated yields.
Table 4. Nucleophile scope in conjugate addition reactions with chromone 1c.
Entry Base Nucleophile Nucleophile Solvent Reaction Yield of 5 Yield of 6c Recovered 1c
[mol-%] [equiv.] time [%][d] [%][d] [%]
1[a] DBU (100) malononitrile 3 DMF 16 h [e]
2[a] DBU (100) malononitrile 6 DMF 16 h [e]
3[a] DBU (50) malononitrile 1 DMF 16 h 23 (5a) – 33
4[a] DBU (50) malononitrile 3 DMF 16 h 28 (5a) – 26
5[a] DBU (50) malononitrile 6 DMF 16 h 26 (5a) – 37
6[a] DBN (50) malononitrile 3 DMF 24 h 21 (5a) – 33
7[a] TBD (50) malononitrile 3 DMF 24 h 19 (5a) – 28
8[a] DABCO (50) malononitrile 3 DMF 72 h 10 (5a) – 37
9[b] DBU (100) acetylacetone – neat 48 h 60 (5b) – traces
10[b] DBU (100) diethyl malonate – neat 24 h 51 (5c) 18[f ] traces
11[c] DBU (100) diethyl malonate – DMF 24 h 60 (5c) 15[f ] traces
12[b] DBU (100) ethyl cyanoacetate – neat 24 h 70 (5d)[f ] – traces
[a] Reaction conditions: chromone 1c (0.1 mmol) in DMF (0.4 mL). [b] Reaction conditions: chromone 1c (0.1 mmol) in nucleophile (0.5 mL). [c] Reaction
conditions: chromone 1c (0.1 mmol) in DMF (0.6 mL) with diethyl malonate (0.4 mL). [d] Isolated yields. [e] Unidentified degradation products. [f ] Mixture of
two diastereomers.
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Nucleophile Scope
Once we had determined the optimal reaction conditions for
the conjugate addition of nitromethane to chromones 1, the
scope of the reaction was extended to other carbon nucleo-
philes (Table 4). The best reaction conditions for the addition
of nitromethane to chromone 1c, that is, 100 mol-% of DBU in
DMF, did not work well for malononitrile and led to several
unidentified byproducts (Table 4, Entries 1 and 2). If the amount
of DBU was reduced to 50 mol-% and different amounts of
malononitrile were used, the 1,6-conjugate addition product 5a
was obtained in low yields (23–28 %), and 26–37 % of the start-
ing chromone was recovered (Table 4, Entries 3–5). Other or-
ganic bases were applied, but none of them improved the yield
of 5a (Table 4, Entries 6–8). For acetylacetone as the nucleophile
under neat conditions, the respective 1,6-addition product 5b
was isolated in good yield (Table 4, Entry 9). The reaction of
chromone 1c with diethyl malonate under neat conditions or
with DMF as the solvent led to the 1,6-addition product 5c in
yields of 51 and 60 %, respectively (Table 4, Entries 10 and 11).
Interestingly, these reactions also afforded the double addition
product 6c as an inseparable mixture of two diastereomers in
a 70:30 ratio (Figure 2A), as a result of the 1,8-conjugate addi-
tion at C-δ, followed by the 1,6-conjugate addition at C-. Fi-
nally, if ethyl cyanoacetate was employed as the nucleophile in
the reaction with chromone 1c, an inseparable mixture of two
diastereomers 5d in a 68:32 ratio was obtained in good yield
(Figure 2B; Table 4, Entry 12).
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Figure 2. Relative stereochemistry of diastereomers I and II of (A) 6c and (B) 5d.
Computational Studies
To understand better the reactivity of carbon nucleophiles with
chromones 1 in conjugate additions, computational calcula-
tions were performed. All of the ground-state structures were
optimized with the M06-2X exchange-correlation (xc) functional
and the 6-31G(d,p) basis set in vacuo without symmetry con-
straints. The energy and frequency calculations were performed
with the 6-311+G(d,p) basis set and the same xc functional. The
effects of the solvent and substituents (methoxy substituent)
on the structure were also investigated for some compounds,
and negligible effect on the energies was found. Thus, to de-
crease the computational cost, only the base structure shown
in Figure 3 without any solvent effects was used to calculate
the Gibbs free energies. All of the calculations were performed
with the Gaussian 09 software.[20]
Figure 4. Gibbs free energy profile for the formation of 5b and 5c through reaction at site 1. TS and I represent the transition states and intermediate
structures, respectively.
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Figure 3. Possible nucleophilic addition sites of chromones 1.
The three possible reactive sites of the chromone for nucleo-
philic addition are presented in Figure 3. The results suggest
that sites 1 and 2 would be the most likely reaction pathways
for the reaction, whereas site 3 resulted in an endergonic type
of reaction with a high activation energy, which would be unfa-
vorable. Thus, only sites 1 and 2 will be discussed further.
The Gibbs free energy diagram of the formation of 5b and
5c for the first reactive site is presented in Figure 4. The forma-
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Figure 5. Gibbs free energy profile for the formation of 5bδ, 5cδ, 6b, and 6c through reaction at site 2. TS and I represent the transition states and intermediate
structures, respectively.
tion of the intermediate is the rate-determining step, as the
protonation step was determined to be a barrierless reaction.
Although 5c is 7.3 kJ mol–1 more stable than 5b, the energies
of their corresponding intermediates are reversed. On the basis
of the experimental yields (Table 4) for 5b (60 %) and 5c (51 %),
the reaction is probably kinetically driven.
The further addition of the nucleophile will not yield stable
products at this site. The formation of 6 starts with the nucleo-
philic addition at reactive site 2, followed by addition at site 1.
The energy profile for the possible formation of 6b and 6c at
site 2 is shown in Figure 5. The results show that the energy
barrier for the transition state in the rate-determining step for
site 1 was significantly lower than that for site 2; therefore, if
the reaction is kinetically driven, then the reaction at site 1
would be the predominant pathway. The formation of 6 is basi-
cally a thermodynamically controlled process, and 6c was con-
sidered to be the most stable structure, especially because the
energy for the formation of the second intermediate [I2(6c)] is
more than 10 kJ mol–1 lower than that for I2(6b).
Functionalization of the 1,6-Conjugate Addition Products
Nitromethane conjugate addition products are commonly used
to prepare biologically relevant heterocycles such as spiro-γ-
lactams,[21] pyrrolidines,[22] and diarylpyrrolines and their iso-
stere N-oxides.[23] Thus, the reduction of the nitro groups of -
(nitromethyl)chromones 2a–2d was considered for the prepara-
tion of primary amine derivatives. The reduction studies started
with -(nitromethyl)chromone 2c, Sn (powder), and HCl (37 %)
in a 1:1 ethanol/dichloromethane mixture by an adaptation of
a previously reported method.[10a] After the complete disap-
pearance of the starting material, hydroxylamine derivative 7
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was obtained in 35 % yield (Table 5, Entry 1). The formation of
this hydroxylamine derivative 7 can be explained by the incom-
plete reduction of the nitro group, which undergoes an intra-
molecular aza-Michael addition to the α,-unsaturated system
of the chromone moiety.[19,23]
Table 5. Reduction of the nitro group of -(nitromethyl)chromone 2c.[a]
Entry Reducing agents Time Yield of 8c Yield of 7
[equiv.] [%][b] [%][b]
1[c] Sn (5)/HCl (5) 6 h – 35
2 Sn (10)/NH4OAc (10) 24 h – –
3[d] Sn (10)/NH4OAc (10) 24 h – –
4 Zn (5)/NH4OAc (5) 4 h 16 25
5 Zn (10)/NH4OAc (10) 2 h 64 –
6 Zn (15)/NH4OAc (15) 30 min 75 –
[a] Reaction conditions: 2c (0.137 mmol) in MeOH/CH2Cl2 (1:1, 5 mL) at room
temperature. [b] Isolated yields. [c] Reaction performed in EtOH/CH2Cl2 (1:1,
5 mL). [d] Activated Sn.
A different proton source and activated Sn were both ineffi-
cient for the reduction of the nitro group (Table 5, Entries 2 and
3). Next, Zn was considered as a reduction agent, as previously
reported for nitrochalcones.[13d] The best reaction conditions
were the use of 15 equiv. of Zn/NH4OAc, which afforded the
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styrylpyrrolidine derivative 8c in 75 % yield (Table 5, Entry 6).
These reaction conditions were extended to derivatives 2a, 2b,
and 2d (Table 6), and the styrylpyrrolidines 8a–8d were ob-
tained in good yields (66–75 %).
Table 6. Reduction of the nitro groups of -(nitromethyl)chromones 2a–2d.[a]
Entry R Yield of 8
[%][b]
1 H 71 (8a)
2 Cl 66 (8b)
3 OMe 75 (8c)
4 Me 66 (8d)
[a] Reaction conditions: -(nitromethyl)chromones 2a–2d (0.137 mmol) with
Zn (powder, 2 mmol) and NH4OAc in MeOH/CH2Cl2 (1:1, 5 mL), 30 min at
room temperature. [b] Isolated yields.
Styrylpyrrolidine derivatives 8a–8d were formed through the
aza-Michael addition of the primary amino group to the α,-
unsaturated system in intermediates 9a–9d with chromone ring
opening, as reported previously (Scheme 4).[10a] The 1H NMR
spectra of styrylpyrrolidines 8a–8d showed two singlets at δ =
9.86–9.88 and 13.75–13.78 ppm, assigned to the NH and OH
protons, respectively, owing to intramolecular hydrogen bonds
with the carbonyl group. It was also possible to observe five
aliphatic signals corresponding to protons 3′-H, 4′-H, and 5′-H
(see Scheme 4 for atom numbering). Furthermore, the coupling
constant between α-H and -H (3Jα-H,-H = 15.7–15.8 Hz) indi-
cates the maintenance of the double bond in a trans configura-
tion.
The presence of a dicarbonyl moiety in 5b allows further
functionalization through the 1,2-addition of aza-nucleophiles
to prepare nitrogen heterocycles. The reaction of 5b with
2 equiv. of hydrazine hydrate afforded the expected pyrazole
derivative 10 [Scheme 5, (i)]. On the other hand, if hydrazine
(5 equiv.) was employed, the bis(pyrazole) derivative 11 was
obtained [Scheme 5, (ii)]. The formation of this compound im-
plies that 10 reacts with hydrazine hydrate by a well-known
pathway (i.e., a 1,4-Michael addition and heterocyclic ring open-
ing, followed by intramolecular hydrazone formation).[24]
Scheme 4. Transformation of -(nitromethyl)chromones 2a–2d into the corresponding styrylpyrrolidine derivatives 8a–8d.
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Scheme 5. Synthesis of pyrazole derivatives 10 and 11. Reaction conditions:
(i) NH2NH2·H2O (50–60 %, 2 equiv.), EtOH, room temperature, 1 h. (ii)
NH2NH2·H2O (50–60 %, 5 equiv.), EtOH, room temperature, 1 h.
The functionalization of adduct 5c was also attempted
through the reduction of the malonate group to the corre-
sponding primary alcohol with LiAlH4. The reaction afforded
several unidentified products; however, it was possible to iso-
late and fully characterize the spiro derivative 12 (Scheme 6).
Scheme 6. Synthesis of spiro derivative 12.
The 1H NMR spectrum of derivative 12 showed aliphatic sig-
nals corresponding to protons 3′-H, 4′-H, 5′-H, 6′-H, and CH2OH
as well as two doublets at δ = 5.74 and 6.69 ppm for 3-H and
4-H (3J3-H,4-H = 9.6 Hz). Moreover, the 13C NMR spectrum showed
a signal at δ = 95.4 ppm, which corresponds to the spiro carbon
atom C-2′ (see Scheme 6 for atom numbering). The proposed
mechanism for the formation of derivative 12 proceeds through
the reduction of the ester groups to primary alcohols in VI,
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Scheme 7. Proposed mechanism for the formation of 12.
followed by an intramolecular Michael addition and chromone
ring opening to give intermediate VII, which undergoes a sec-
ond intramolecular Michael addition to yield VIII. Then, a carb-
onyl reduction and dehydration of this intermediate afford the
spiro compound 12 (Scheme 7).
Conclusions
-(Nitromethyl)chromones were the major products of the DBU-
catalyzed 1,6-conjugate addition of nitromethane to 2-[(1E,3E)-
4-arylbuta-1,3-dien-1-yl]-4H-chromen-4-ones. Stoichiometric
amounts of DBU are required for the reaction to proceed
smoothly, and it was possible to direct the regioselectivity of
the reaction towards the 1,6-conjugate addition by limiting the
amount of nitromethane. The formation of minor compounds
such as nitromethyl(styryl)biphenols and spirocyclohexanes oc-
curs because of the competition between 1,6- and 1,8-conju-
gate additions in this extended 3,2:α,:γ,δ-triunsaturated sys-
tem. The scope of the reaction was extended to other carbon
nucleophiles, and the major products were obtained from the
1,6-conjugate addition of malononitrile, acetylacetone, diethyl
malonate, and ethyl cyanoacetate to the starting chromones.
For diethyl malonate, we also obtained a minor product result-
ing from consecutive 1,8- and 1,6-conjugate addition reactions.
Computational calculations showed that the reaction is proba-
bly kinetically driven towards 1,6-addition, and the products
from reaction at the δ position are formed through a thermody-
namically controlled process. The reduction of the nitro groups
of the -(nitromethyl)chromones afforded primary amine deriv-
atives, which underwent intramolecular aza-Michael additions
to the α,-unsaturated system of the chromone nucleus to af-
ford styrylpyrrolidine derivatives. Further functionalization of
the acetylacetone adduct through reaction with hydrazine
hydrate gave a pyrazole or bis(pyrazole) derivative depending
on the amount of nucleophile.
Experimental Section
The melting points were measured with a Büchi B-540 melting-
point apparatus. The NMR spectra were recorded with a Bruker
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Avance 300 spectrometer (300.13 MHz for 1H and 75.47 MHz for
13C) or a Bruker Avance 500 spectrometer (500.13 MHz for 1H and
125.77 MHz for 13C). The chemical shifts (δ) are reported in ppm,
and the coupling constants (J) are in Hz; the internal standard was
tetramethylsilane (TMS). Unequivocal 13C NMR assignments were
made with the aid of 2D gradient heteronuclear single quantum
coherence (gHSQC) and gradient HMBC (gHMBC, the delays for
one-bond JC,H couplings were optimized for 145 and 7 Hz, respec-
tively) experiments. Positive-ion ESI mass spectra were acquired
with a QTOF 2 instrument [the sample (1 μL) in chloroform solution
(ca. 10–5 M) was diluted in 0.1 % trifluoroacetic acid/methanol solu-
tion (200 μL); nitrogen was used as the nebulizer gas, and argon
was used as the collision gas; the needle voltage was set to 3000 V,
the ion source was set to 80 °C, and the desolvation temperature
was set to 150 °C; the cone voltage was 35 V]. Other low- and high-
resolution mass spectra (EI, 70 eV) were measured with VG Auto-
spec Q and M spectrometers. Preparative thin-layer chromatogra-
phy was performed with Merck silica gel (60 DGF254). All chemicals
and solvents used were obtained from commercial sources and
used as received or dried by standard procedures.
General Procedure for the Synthesis of 2a–2d, 3a–3d, and 4a–
4d: DBU (0.1 mmol, 14.9 μL) was added to a mixture of the appro-
priate chromone 1a–1d (0.1 mmol) in nitromethane (0.4 mL). The
resulting mixture was stirred at room temperature for 1 h and then
poured into water (5 mL), and the pH was adjusted to 4 with dilute
HCl. The aqueous mixture was extracted with dichloromethane (3 ×
5 mL), dried with anhydrous sodium sulfate, and concentrated un-
der reduced pressure. The residue was purified by preparative TLC
with dichloromethane as the eluent to afford derivatives 2a–2d
(higher Rf values), 3a–3d, and 4a–4d (lower Rf value).
(E)-2-[2-(Nitromethyl)-4-phenylbut-3-en-1-yl]-4H-chromen-4-
one (2a): Yield 13.4 mg (40 %), colorless oil. 1H NMR (300 MHz,
CDCl3): δ = 2.71–3.04 (m, 2 H, α-H), 3.58–3.70 (m, 1 H, -H), 4.53
(dd, J = 12.4, 7.5 Hz, 1 H, NO2CH2), 4.58 (dd, J = 12.4, 6.7 Hz, 1 H,
NO2CH2), 6.03 (dd, J = 15.8, 8.8 Hz, 1 H, γ-H), 6.23 (s, 1 H, 3-H), 6.55
(dd, J = 15.8, 0.8 Hz, 1 H, δ-H), 7.23–7.31 (m, 5 H, 2′-H, 3′-H, 4′-H,
5′-H, 6′-H), 7.40 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H, 6-H), 7.45 (dd, J = 8.6,
1.0 Hz, 1 H, 8-H), 7.67 (ddd, J = 8.6, 7.1, 1.7 Hz, 1 H, 7-H), 8.17 (dd,
J = 8.0, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 37.2
(C-α), 39.8 (C-), 78.7 (NO2CH2), 111.9 (C-3), 117.8 (C-8), 123.6 (C-4a),
125.0 (C-γ), 125.4 (C-6), 125.8 (C-5), 126.5 (C-2′, C-6′), 128.3 (C-4′),
128.7 (C-3′, C-5′), 133.9 (C-7), 134.6 (C-δ), 135.7 (C-1′), 156.3 (C-8a),
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164.9 (C-2), 177.9 (C-4) ppm. ESI-HRMS: calcd. for C20H18NO4 [M +
H]+ 336.1236; found 336.1226.
(E)-2-[4-(4-Chlorophenyl)-2-(nitromethyl)but-3-en-1-yl]-4H-
chromen-4-one (2b): Yield 14.0 mg (38 %), colorless oil. 1H NMR
(300 MHz, CDCl3): δ = 2.85 (dd, J = 14.5, 8.0 Hz, 1 H, α-H), 2.93 (dd,
J = 14.5, 6.4 Hz, 1 H, α-H), 3.57–3.69 (m, 1 H, -H), 4.49–4.62 (m, 2
H, NO2CH2), 6.01 (dd, J = 15.8, 8.8 Hz, 1 H, γ-H), 6.22 (s, 1 H, 3-H),
6.50 (d, J = 15.8 Hz, 1 H, δ-H), 7.20 (d, J = 8.5 Hz, 2 H, 2′-H, 6′-H),
7.26 (d, J = 8.5 Hz, 2 H, 3′-H, 5′-H), 7.41 (ddd, J = 8.0, 7.1, 1.1 Hz, 1
H, 6-H), 7.44 (dd, J = 8.7, 1.1 Hz, 1 H, 8-H), 7.68 (ddd, J = 8.7, 7.1,
1.7 Hz, 1 H, 7-H), 8.17 (dd, J = 8.0, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 37.1 (C-α), 39.9 (C-), 78.6 (NO2CH2), 111.9 (C-
3), 117.8 (C-8), 123.6 (C-4a), 125.5 (C-6), 125.7 (C-γ), 125.8 (C-5), 127.7
(C-2′, C-6′), 128.8 (C-3′, C-5′), 133.5 (C-δ), 133.9 (C-7), 134.0, 134.2
(C-1′, C-4′), 156.3 (C-8a), 164.7 (C-2), 177.9 (C-4) ppm. ESI-HRMS:
calcd. for C20H1735ClNO4 [M + H]+ 370.0846; found 370.0836; calcd.
for C20H1737ClNO4 [M + H]+ 372.0817; found 372.0803.
(E)-2-[4-(4-Methoxyphenyl)-2-(nitromethyl)but-3-en-1-yl]-4H-
chromen-4-one (2c): Yield 19.0 mg (52 %), white solid, m.p. 139–
141 °C. 1H NMR (300 MHz, CDCl3): δ = 2.84 (dd, J = 14.5, 8.0 Hz, 1
H, α-H), 2.92 (dd, J = 14.5, 6.5 Hz, 1 H, α-H), 3.58–3.70 (m, 1 H, -
H), 3.79 (s, 3 H, OCH3), 4.51 (dd, J = 12.3, 7.5 Hz, 1 H, NO2CH2), 4.57
(dd, J = 12.3, 6.7 Hz, 1 H, NO2CH2), 5.87 (dd, J = 15.7, 8.8 Hz, 1 H,
γ-H), 6.22 (s, 1 H, 3-H), 6.49 (d, J = 15.7 Hz, 1 H, δ-H), 6.82 (d, J =
8.7 Hz, 2 H, 3′-H, 5′-H), 7.22 (d, J = 8.7 Hz, 2 H, 2′-H, 6′-H), 7.40 (ddd,
J = 8.0, 7.1, 1.1 Hz, 1 H, 6-H), 7.45 (dd, J = 8.7, 1.1 Hz, 1 H, 8-H), 7.67
(ddd, J = 8.7, 7.1, 1.6 Hz, 1 H, 7-H), 8.17 (dd, J = 8.0, 1.6 Hz, 1 H, 5-
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 37.3 (C-α), 39.9 (C-), 55.3
(OCH3), 78.9 (NO2CH2), 111.9 (C-3), 114.0 (C-3′, C-5′), 117.8 (C-8),
122.6 (C-γ), 123.7 (C-4a), 125.4 (C-6), 125.8 (C-5), 127.7 (C-2′, C-6′),
128.5 (C-1′), 133.9 (C-7), 134.0 (C-δ), 156.3 (C-8a), 159.7 (C-4′), 165.0
(C-2), 177.9 (C-4) ppm. ESI-HRMS: calcd. for C21H20NO5 [M + H]+
366.1341; found 366.1330.
(E)-2-[4-(Methylphenyl)-2-(nitromethyl)but-3-en-1-yl]-4H-
chromen-4-one (2d): Yield 14.0 mg (40 %), white solid, m.p. 103–
104 °C. 1H NMR (300 MHz, CDCl3): δ = 2.31 (s, 3 H, CH3), 2.84 (dd,
J = 14.5, 8.0 Hz, 1 H, α-H), 2.92 (dd, J = 14.5, 6.6 Hz, 1 H, α-H), 3.56–
3.68 (m, 1 H, -H), 4.52 (dd, J = 12.3, 7.5 Hz, 1 H, NO2CH2), 4.57 (dd,
J = 12.3, 6.7 Hz, 1 H, NO2CH2), 5.97 (dd, J = 15.8, 8.7 Hz, 1 H, γ-H),
6.23 (s, 1 H, 3-H), 6.52 (d, J = 15.8 Hz, 1 H, δ-H), 7.09 (d, J = 8.1 Hz,
2 H, 3′-H, 5′-H), 7.18 (d, J = 8.1 Hz, 2 H, 2′-H, 6′-H), 7.40 (ddd, J =
8.0, 7.1, 1.0 Hz, 1 H, 6-H), 7.45 (dd, J = 8.5, 1.0 Hz, 1 H, 8-H), 7.67
(ddd, J = 8.5, 7.1, 1.7 Hz, 1 H, 7-H), 8.17 (dd, J = 8.0, 1.7 Hz, 1 H, 5-
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 21.2 (CH3), 37.3 (C-α), 39.9
(C-), 78.8 (NO2CH2), 111.9 (C-3), 117.8 (C-8), 123.7 (C-4a), 123.9 (C-
γ), 125.4 (C-6), 125.8 (C-5), 126.4 (C-2′, C-6′), 129.3 (C-3′, C-5′), 132.9
(C-1′), 133.9 (C-7), 134.5 (C-δ), 138.3 (C-4′), 156.3 (C-8a), 164.9 (C-2),
177.9 (C-4) ppm. ESI-HRMS: calcd. for C21H20NO4 [M + H]+ 350.1392;
found 350.1385.
(E)-5′-(Nitromethyl)-3′-styryl-[1,1′-biphenyl]-2-ol (3a): Yield
2.3 mg (7 %), colorless oil. 1H NMR (500 MHz, CDCl3): δ = 5.16 (s, 1
H, OH), 5.52 (s, 2 H, NO2CH2), 6.99 (dd, J = 8.6, 1.1 Hz, 1 H, 3-H),
7.04 (dt, J = 7.5, 1.1 Hz, 1 H, 5-H), 7.14 (AB, J = 16.3 Hz, 1 H, α-H),
7.20 (AB, J = 16.3 Hz, 1 H, -H), 7.29–7.31 (m, 3 H, 4-H, 6-H, 4′′-H),
7.38 (t, J = 7.6 Hz, 2 H, 3′′-H, 5′′-H), 7.48 (t, J = 1.6 Hz, 1 H, 6′-H),
7.52–7.54 (m, 2 H, 2′′-H, 6′′-H), 7.61 (t, J = 1.6 Hz, 1 H, 4′-H), 7.72 (t,
J = 1.6 Hz, 1 H, 2′-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 79.9
(NO2CH2), 116.2 (C-3), 121.2 (C-5), 126.7 (C-2′′, C-6′′), 126.8 (C-1),
127.0 (C-α), 127.2 (C-4′), 128.2 (C-4′′), 128.6 (C-2′), 128.8 (C-3′′, C-5′′
), 129.69, 129.70 (C-4, C-6′), 130.4 (C-6), 130.80 (C-), 130.85 (C-5′),
136.7 (C-1′′), 138.8 (C-1′), 139.2 (C-3′), 152.4 (C-2) ppm. ESI-HRMS:
calcd. for C21H16NO3 [M – H]– 330.1130; found 330.1133.
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(E)-3′-(4-Chlorostyryl)-5′-(nitromethyl)-[1,1′-biphenyl]-2-ol (3b):
Yield 5.5 mg (15 %), colorless oil. 1H NMR (500 MHz, CDCl3): δ =
5.14 (s, 1 H, OH), 5.52 (s, 2 H, NO2CH2), 6.99 (dd, J = 7.6, 1.2 Hz, 1
H, 3-H), 7.04 (dt, J = 7.5, 1.2 Hz, 1 H, 5-H), 7.10 (AB, J = 16.3 Hz, 1
H, α-H), 7.15 (AB, J = 16.3 Hz, 1 H, -H), 7.29 (d, J = 7.5 Hz, 1 H, 6-
H), 7.28–7.32 (m, 1 H, 4-H), 7.35 (d, J = 8.5 Hz, 2 H, 3′′-H, 5′′-H), 7.45
(d, J = 8.5 Hz, 2 H, 2′′-H, 6′′-H), 7.49 (t, J = 1.6 Hz, 1 H, 6′-H), 7.59 (t,
J = 1.6 Hz, 1 H, 4′-H), 7.71 (t, J = 1.6 Hz, 1 H, 2′-H) ppm. 13C NMR
(125 MHz, CDCl3): δ = 79.9 (NO2CH2), 116.2 (C-3), 121.2 (C-5), 126.9
(C-1), 127.1 (C-4′), 127.7 (C-α), 127.9 (C-2′′, C-6′′), 128.7 (C-2′), 129.0
(C-3′′, C-5′′), 129.44 (C-), 129.7 (C-4), 129.9 (C-6′), 130.4 (C-6), 130.9
(C-5′), 133.8 (C-4′′), 135.2 (C-1′′), 138.8, 138.9 (C-1′, C-3′), 152.4 (C-2)
ppm. ESI-HRMS: calcd. for C21H1535ClNO3 [M – H]– 364.0740; found
364.0748; calcd. for C21H1537ClNO3 [M – H]– 366.0711; found
366.0716.
(E)-3′-(4-Methoxystyryl)-5′-(nitromethyl)-[1,1′-biphenyl]-2-ol
(3c): Yield 6.5 mg (18 %), yellowish oil. 1H NMR (500 MHz, CDCl3):
δ = 3.84 (s, 3 H, OCH3), 5.14 (s, 1 H, OH), 5.51 (s, 2 H, NO2CH2), 6.92
(d, J = 8.7 Hz, 2 H, 3′′-H, 5′′-H), 6.99 (dd, J = 7.5, 1.0 Hz, 1 H, 3-H),
7.00 (d, J = 16.3 Hz, 1 H, α-H), 7.03 (dt, J = 7.5, 1.0 Hz, 1 H, 5-H),
7.15 (d, J = 16.3 Hz, 1 H, -H), 7.28–7.31 (m, 1 H, 4-H), 7.29 (d, J =
7.5 Hz, 1 H, 6-H), 7.44 (t, J = 1.6 Hz, 1 H, 6′-H), 7.47 (d, J = 8.7 Hz, 2
H, 2′′-H, 6′′-H), 7.58 (t, J = 1.6 Hz, 1 H, 4′-H), 7.68 (t, J = 1.6 Hz, 1 H,
2′-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 55.4 (OCH3), 79.9
(NO2CH2), 114.3 (C-3′′, C-5′′), 116.1 (C-3), 121.1 (C-5), 124.8 (C-α),
126.9 (C-4′), 127.1 (C-1), 128.0 (C-2′′, C-6′′), 128.3 (C-2′), 129.2 (C-6′),
129.4 (C-1′′), 129.6 (C-4), 130.33, 130.35 (C-6, C-), 130.8 (C-5′), 138.7
(C-1′), 139.6 (C-3′), 152.4 (C-2), 159.8 (C-4′′) ppm. ESI-HRMS: calcd.
for C22H18NO4 [M – H]– 360.1236; found 360.1236.
(E)-3′-(4-Methylstyryl)-5′-(nitromethyl)-[1,1′-biphenyl]-2-ol (3d):
Yield 1.0 mg (3 %), colorless oil. 1H NMR (500 MHz, CDCl3): δ = 2.37
(s, 3 H, CH3), 5.14 (s, 1 H, OH), 5.51 (s, 2 H, NO2CH2), 6.99 (dd, J =
8.5, 1.2 Hz, 1 H, 3-H), 7.03 (dt, J = 7.5, 1.2 Hz, 1 H, 5-H), 7.09 (d, J =
16.3 Hz, 1 H, α-H), 7.17 (d, J = 16.3 Hz, 1 H, -H), 7.19 (d, J = 8.0 Hz,
2 H, 3′′-H, 5′′-H), 7.29 (d, J = 7.5 Hz, 1 H, 6-H), 7.28–7.31 (m, 1 H, 4-
H), 7.43 (d, J = 8.0 Hz, 2 H, 2′′-H, 6′′-H), 7.46 (t, J = 1.7 Hz, 1 H, 6′-
H), 7.59 (t, J = 1.7 Hz, 1 H, 4′-H), 7.70 (t, J = 1.7 Hz, 1 H, 2′-H) ppm.
13C NMR (125 MHz, CDCl3): δ = 21.3 (CH3), 79.9 (NO2CH2), 116.2 (C-
3), 121.2 (C-5), 126.0 (C-α), 126.66 (C-2′′, C-6′′), 126.71 (C-1), 127.1
(C-4′), 128.5 (C-2′), 129.4 (C-6′), 129.5 (C-3′′, C-5′′), 129.7 (C-4), 130.3
(C-), 130.7 (C-6), 130.8 (C-5′), 133.9 (C-1′′), 138.3 (C-4′′), 138.7
(C-1′), 139.4 (C-3′), 152.4 (C-2) ppm. ESI-HRMS: calcd. for C22H18NO3
[M – H]– 344.1287; found 344.1278.
2′-Nitro-5′-(nitromethyl)-3′-phenylspiro[chromane-2,1′-cyclo-
hexan]-4-one (4a): Yield 2.4 mg (6 %), colorless oil. 1H NMR
(500 MHz, CDCl3): δ = 1.38 (dd, 1 H, 6′-H, J = 14.5, 12.6 Hz), 1.50–
1.58 (m, 1 H, 4′-H), 2.19 (dq, J = 13.6, 3.5 Hz, 1 H, 4′-H), 2.53 (dt, J =
14.5, 3.5 Hz, 1 H, 6′-H), 2.70–2.79 (m, 1 H, 5′-H), 2.73 (d, J = 16.7 Hz,
1 H, 3-H), 3.15 (d, 1 H, 3-H, J = 16.7 Hz), 4.12 (dt, 1 H, 3′-H, J = 12.2,
3.5 Hz), 4.19 (dd, 1 H, NO2CH2, J = 12.5, 7.4 Hz), 4.24 (dd, 1 H,
NO2CH2, J = 12.5, 6.0 Hz), 4.81 (d, 1 H, 2′-H, J = 12.2 Hz), 7.11 (ddd,
1 H, 6-H, J = 7.8, 7.1, 1.0 Hz), 7.18 (dd, 1 H, 8-H, J = 8.2, 1.0 Hz),
7.28–7.30 (m, 3 H, 2′′,4′′,6′′-H), 7.33–7.36 (m, 2 H, 3′′-H, 5′′-H), 7.60
(ddd, J = 8.2, 7.1, 1.7 Hz, 1 H, 7-H), 7.88 (dd, J = 7.8, 1.7 Hz, 1 H, 5-
H) ppm. 13C NMR (125 MHz, CDCl3): δ = 31.0 (C-5′), 35.0 (C-6′), 36.2
(C-4′), 41.2 (C-3′), 44.8 (C-3), 78.5 (C-1′), 79.2 (NO2CH2), 93.8 (C-2′),
118.4 (C-8), 119.9 (C-4a), 122.5 (C-6), 126.8 (C-5), 127.2 (C-2′′, C-6′′),
128.2 (C-4′′), 129.2 (C-3′′, C-5′′), 137.1 (C-7), 138.7 (C-1′′), 157.2 (C-
8a), 189.5 (C-4) ppm. ESI-HRMS: calcd. for C21H21N2O6 [M + H]+
397.1400; found 397.1412.
3′-(4-Chlorophenyl)-2′-nitro-5′-(nitromethyl)spiro[chromane-
2,1′-cyclohexan]-4-one (4b): Yield 4.3 mg (10 %), colorless oil. 1H
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NMR (300 MHz, CDCl3): δ = 1.37 (dd, J = 14.4, 12.7 Hz, 1 H, 6′-H),
1.45–1.59 (m, 1 H, 4′-H), 2.17 (dq, J = 14.6, 3.5 Hz, 1 H, 4′-H), 2.53
(dt, J = 14.4, 3.5 Hz, 1 H, 6′-H), 2.66–2.80 (m, 1 H, 5′-H), 2.72 (d, J =
16.7 Hz, 1 H, 3-H), 3.14 (d, J = 16.7 Hz, 1 H, 3-H), 4.11 (dt, J = 12.1,
3.5 Hz, 1 H, 3′-H), 4.21 (dd, J = 12.7, 7.7 Hz, 1 H, NO2CH2), 4.25 (dd,
J = 12.7, 6.2 Hz, 1 H, NO2CH2), 4.75 (d, J = 12.1 Hz, 1 H, 2′-H), 7.12
(ddd, J = 7.9, 7.3, 1.0 Hz, 1 H, 6-H), 7.16 (dd, J = 8.7, 1.0 Hz, 1 H, 8-
H), 7.23 (d, J = 8.5 Hz, 2 H, 2′′-H, 6′′-H), 7.33 (d, J = 8.5 Hz, 2 H, 3′′-
H, 5′′-H), 7.60 (ddd, J = 8.7, 7.3, 1.8 Hz, 1 H, 7-H), 7.88 (dd, J = 7.9,
1.8 Hz, 1 H, 5-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 30.9 (C-5′),
35.0 (C-6′), 36.0 (C-4′), 40.7 (C-3′), 44.7 (C-3), 78.4 (C-1′), 79.1
(NO2CH2), 93.7 (C-2′), 118.3 (C-8), 119.9 (C-4a), 122.6 (C-6), 126.9 (C-
5), 128.6 (C-2′′, C-6′′), 129.4 (C-3′′, C-5′′), 134.1 (C-4′′), 137.10, 137.15
(C-7, C-1′′), 157.1 (C-8a), 189.3 (C-4) ppm. ESI-HRMS: calcd. for
C21H1835ClN2O6 [M – H]– 429.0853; found 429.0860; calcd. for
C21H1837ClN2O6 [M – H]– 431.0824; found 431.0830.
3′-(4-Methoxyphenyl)-2′-nitro-5′-(nitromethyl)spiro[chromane-
2,1′-cyclohexan]-4-one (4c): Yield 5.1 mg (12 %), colorless oil. 1H
NMR (500 MHz, CDCl3): δ = 1.35 (dd, J = 14.4, 12.6 Hz, 1 H, 6′-H),
1.48–1.56 (m, 1 H, 4′-H), 2.16 (dq, J = 13.8, 3.6 Hz, 1 H, 4′-H), 2.52
(dt, J = 14.4, 3.6 Hz, 1 H, 6′-H), 2.70–2.77 (m, 1 H, 5′-H), 2.71 (d, J =
16.7 Hz, 1 H, 3-H), 3.13 (d, J = 16.7 Hz, 1 H, 3-H), 3.79 (s, 3 H, OCH3),
4.06 (dt, J = 12.2, 3.6 Hz, 1 H, 3′-H), 4.19 (dd, J = 12.5, 7.4 Hz, 1 H,
NO2CH2), 4.24 (dd, J = 12.5, 6.0 Hz, 1 H, NO2CH2) 4.73 (d, J = 12.2 Hz,
1 H, 2′-H), 6.87 (d, J = 8.7 Hz, 2 H, 3′′-H, 5′′-H), 7.11 (ddd, J = 7.9,
7.2, 1.0 Hz, 1 H, 6-H), 7.17 (dd, J = 8.4, 1.0 Hz, 1 H, 8-H), 7.21 (d, J =
8.7 Hz, 2 H, 2′′-H,6′′-H), 7.59 (ddd, J = 8.4, 7.2, 1.7 Hz, 1 H, 7-H), 7.88
(dd, J = 7.9, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR (125 MHz, CDCl3): δ =
31.0 (C-5′), 35.0 (C-6′), 36.2 (C-4′), 40.4 (C-3′), 44.8 (C-3), 55.3 (OCH3),
78.5 (C-1′), 79.2 (NO2CH2), 94.2 (C-2′), 114.5 (C-3′′, C-5′′), 118.4 (C-8),
119.9 (C-4a), 122.5 (C-6), 126.8 (C-5), 128.3 (C-2′′, C-6′′), 130.6
(C-1′′), 137.0 (C-7), 157.3 (C-8a), 159.3 (C-4′′), 189.5 (C-4) ppm. ESI-
HRMS: calcd. for C22H21N2O7 [M – H]– 425.1349; found 425.1356.
3′-(4-Methylphenyl)2′-nitro-5′-(nitromethyl)spiro[chromane-
2,1′-cyclohexan]-4-one (4d): Yield 3.3 mg (8 %), colorless oil. 1H
NMR (300 MHz, CDCl3): δ = 1.36 (dd, J = 14.3, 12.6 Hz, 1 H, 6′-H),
1.44–1.60 (m, 1 H, 4′-H), 2.16 (dq, J = 13.6, 3.7 Hz, 1 H, 4′-H), 2.32
(s, 3 H, CH3), 2.52 (dt, J = 14.3, 3.7 Hz, 1 H, 6′-H), 2.66–2.80 (m, 1 H,
5′-H), 2.72 (d, J = 16.7 Hz, 1 H, 3-H), 3.14 (d, J = 16.7 Hz, 1 H, 3-H),
4.08 (dt, J = 12.3, 3.7 Hz, 1 H, 3′-H), 4.18 (dd, J = 12.3, 7.1 Hz, 1 H,
NO2CH2), 4.24 (dd, J = 12.3, 6.1 Hz, 1 H, NO2CH2), 4.78 (d, J = 12.3 Hz,
1 H, 2′-H), 7.11 (ddd, J = 8.0, 7.2, 1.1 Hz, 1 H, 6-H), 7.13–7.16 (m, 1
H, 8-H), 7.14 (AA′BB′, J = 8.5 Hz, 2 H, 3′′-H, 5′′-H), 7.18 (AA′BB′, J =
8.5 Hz, 2 H, 2′′-H, 6′′-H), 7.59 (ddd, J = 8.8, 7.2, 1.7 Hz, 1 H, 7-H),
7.88 (dd, J = 8.0, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR (75 MHz, CDCl3):
δ = 21.0 (CH3), 31.0 (C-5′), 35.0 (C-6′), 36.2 (C-4′), 40.8 (C-3′), 44.8 (C-
3), 78.5 (C-1′), 79.2 (NO2CH2), 94.0 (C-2′), 118.4 (C-8), 119.9 (C-4a),
122.5 (C-6), 126.8 (C-5), 127.0 (C-2′′, C-6′′), 129.8 (C-3′′, C-5′′), 135.6
(C-1′′), 137.0 (C-7), 137.9 (C-4′′), 157.3 (C-8a), 189.5 (C-4) ppm. ESI-
HRMS: calcd. for C22H21N2O6 [M – H]– 409.1400; found 409.1402.
(E)-2-[4-(4-Methoxyphenyl)-1-(4-oxo-4H-chromen-2-yl)but-3-en-
2-yl]malononitrile (5a): DBU (0.05 mmol, 7.5 μL) was added to a
solution of chromone 1c (0.1 mmol, 30 mg) and malononitrile
(0.3 mmol, 19.8 mg) in dry DMF (0.4 mL). The reaction mixture was
stirred at room temperature for 16 h and then poured into water
(5 mL), and the pH was adjusted to 4 with dilute HCl. The aqueous
mixture was extracted with dichloromethane (3 × 5 mL), dried with
anhydrous sodium sulfate, and concentrated under reduced pres-
sure. The crude residue was purified by preparative TLC with hex-
ane/ethyl acetate (9:7) as the eluent. Yield 10.4 mg (28 %), brown
oil. 1H NMR (300 MHz, CDCl3): δ = 3.02 (dd, J = 14.6, 8.3 Hz, 1 H, α-
H), 3.12 (dd, J = 14.6, 6.5 Hz, 1 H, α-H), 3.38–3.48 (m, 1 H, -H), 3.80
Eur. J. Org. Chem. 2017, 5293–5305 www.eurjoc.org © 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim5302
(s, 3 H, OCH3), 3.97 [d, J = 4.9 Hz, 1 H, CH(CN)2], 5.96 (dd, J = 15.6,
9.1 Hz, 1 H, γ-H), 6.27 (s, 1 H, 3-H), 6.67 (d, J = 15.6 Hz, 1 H, δ-H),
6.85 (d, J = 8.7 Hz, 2 H, 3′-H, 5′-H), 7.29 (d, J = 8.7 Hz, 2 H, 2′-H, 6′-
H), 7.41 (ddd, J = 7.9, 7.1, 0.9 Hz, 1 H, 6-H), 7.45 (d, J = 8.3 Hz, 1 H,
8-H), 7.69 (ddd, J = 8.3, 7.1, 1.7 Hz, 1 H, 7-H), 8.16 (dd, J = 7.9, 1.7 Hz,
1 H, 5-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 28.6 [CH(CN)2], 37.2
(C-α), 42.6 (C-), 55.4 (OCH3), 111.0, 111.3 [CH(CN)2], 112.3 (C-3),
114.2 (C-3′, C-5′), 117.8 (C-8), 119.8 (C-γ), 123.6 (C-4a), 125.6 (C-6),
125.9 (C-5), 127.6 (C-1′), 128.2 (C-2′, C-6′), 134.1 (C-7), 136.8 (C-δ),
156.3 (C-8a), 160.2 (C-4′), 163.4 (C-2), 177.7 (C-4) ppm. ESI-MS: m/z
(%) = 371 (100) [M + H]+, 372 (25) [M + 2H]+. ESI-HRMS: calcd. for
C23H19N2O3 [M + H]+ 371.1390; found 371.1374.
(E)-3-[4-(4-Methoxyphenyl)-1-(4-oxo-4H-chromen-2-yl)but-3-en-
2-yl]pentane-2,4-dione (5b): DBU (0.1 mmol, 14.9 μL) was added
to a solution of chromone 1c (0.1 mmol, 30 mg) in acetylacetone
(0.5 mL). The resulting mixture was stirred at room temperature for
48 h and then poured into water (5 mL), and the pH was adjusted
to 4 with dilute HCl. The aqueous mixture was extracted with di-
chloromethane (3 × 5 mL), dried with anhydrous sodium sulfate,
and concentrated under reduced pressure. The crude residue was
purified by preparative TLC with hexane/ethyl acetate (9:7) as the
eluent. Yield 24.3 mg (60 %), colorless oil. 1H NMR (300 MHz, CDCl3):
δ = 2.14 (s, 3 H, 4′′-CH3), 2.27 (s, 3 H, 2′′-CH3), 2.63 (dd, J = 14.2,
9.5 Hz, 1 H, α-H), 2.82 (dd, J = 14.2, 4.3 Hz, 1 H, α-H), 3.58 (dq, J =
9.5, 4.3 Hz, 1 H, -H), 3.77 (s, 3 H, OCH3), 3.90 (d, J = 9.5 Hz, 1 H,
3′′-H), 5.83 (dd, J = 15.8, 9.5 Hz, 1 H, γ-H), 6.15 (s, 1 H, 3-H), 6.36 (d,
J = 15.8 Hz, 1 H, δ-H), 6.78 (d, J = 8.7 Hz, 2 H, 3′-H, 5′-H), 7.15 (d,
J = 8.7 Hz, 2 H, 2′-H, 6′-H), 7.38 (ddd, J = 8.0, 7.1, 1.0 Hz, 1 H, 6-H),
7.43 (dd, J = 8.5, 1.0 Hz, 1 H, 8-H), 7.65 (ddd, J = 8.5, 7.1, 1.7 Hz, 1
H, 7-H), 8.15 (dd, J = 8.0, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 29.6 (4′′-CH3), 30.3 (2′′-CH3), 38.2 (C-α), 41.2 (C-), 55.3
(OCH3), 73.1 (C-3′′), 111.8 (C-3), 114.0 (C-3′, C-5′), 117.8 (C-8), 123.7
(C-4a), 124.4 (C-γ), 125.2 (C-6), 125.8 (C-5), 127.6 (C-2′, C-6′), 128.8
(C-1′), 133.2 (C-δ), 133.7 (C-7), 156.4 (C-8a), 159.5 (C-4′), 166.2 (C-2),
178.0 (C-4), 202.6, 202.7 (C-2′′, C-4′′) ppm. ESI-MS: m/z (%) = 405
(100) [M + H]+, 406 (28) [M + 2H]+. ESI-HRMS: calcd. for C25H25O5
[M + H]+ 405.1697; found 405.1682.
Diethyl (E)-2-[4-(4-Methoxyphenyl)-1-(4-oxo-4H-chromen-2-
yl)but-3-en-2-yl]malonate (5c): DBU (0.1 mmol, 14.9 μL) was
added to a mixture of chromone 1c (0.1 mmol, 30 mg) and diethyl
malonate (0.4 mL) in dry DMF (0.6 mL). The solution was stirred at
room temperature for 24 h and then poured into water (5 mL), and
the pH was adjusted to 4 with dilute HCl. The aqueous mixture was
extracted with dichloromethane (3 × 5 mL), dried with anhydrous
sodium sulfate, and concentrated under reduced pressure. The
crude residue was purified by preparative TLC with hexane/ethyl
acetate (9:7) as the eluent to afford the desired product 5c (higher
Rf value) and compound 6c (colorless oil, lower Rf value) as an in-
separable mixture of two diastereomers.
Diethyl (E)-2-[4-(4-Methoxyphenyl)-1-(4-oxo-4H-chromen-2-
yl)but-3-en-2-yl]malonate (5c): Yield 27.9 mg (60 %), colorless oil.
1H NMR (300 MHz, CDCl3): δ = 1.21, 1.27 (2 × t, J = 7.1 Hz, 6 H,
CO2CH2CH3), 2.82 (dd, J = 14.3, 8.7 Hz, 1 H, α-H), 3.02 (dd, J = 14.3,
4.8 Hz, 1 H, α-H), 3.44–3.54 (m, 1 H, -H), 3.56 (d, J = 7.9 Hz, 1 H,
1′′-H), 3.77 (s, 3 H, OCH3), 4.16, 4.22 (2 × dq, J = 7.1, 0.8 Hz, 4 H,
CO2CH2CH3), 6.00 (dd, J = 15.7, 9.0 Hz, 1 H, γ-H), 6.19 (s, 1 H, 3-H),
6.38 (d, J = 15.7 Hz, 1 H, δ-H), 6.78 (d, J = 8.8 Hz, 2 H, 3′-H, 5′-H),
7.18 (d, J = 8.8 Hz, 2 H, 2′-H, 6′-H), 7.37 (ddd, J = 8.0, 7.1, 1.1 Hz, 1
H, 6-H), 7.43 (dd, J = 8.3, 1.1 Hz, 1 H, 8-H), 7.64 (ddd, J = 8.3, 7.1,
1.7 Hz, 1 H, 7-H), 8.15 (dd, J = 8.0, 1.7 Hz, 1 H, 5-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 14.1 (CO2CH2CH3), 37.9 (C-α), 41.4 (C-), 55.3
(OCH3), 56.1 (C-1′′), 61.62, 61.75 (CO2CH2CH3), 111.6 (C-3), 113.9
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(C-3′, C-5′), 117.9 (C-8), 123.7 (C-4a), 124.8 (C-γ), 125.1 (C-6), 125.7
(C-5), 127.5 (C-2′, C-6′), 129.2 (C-1′), 132.9 (C-δ), 133.6 (C-7), 156.4
(C-8a), 159.3 (C-4′), 166.6 (C-2), 167.7, 167.9 (CO2CH2CH3), 178.1 (C-
4) ppm. ESI-MS: m/z (%) = 465 (100) [M + H]+, 466 (30) [M + 2H]+.
ESI-HRMS: calcd. for C27H29O7 [M + H]+ 465.1908; found 465.1891.
Tetraethyl rel-(2S,4R)-2-(4-Methoxyphenyl)-4-[(4-oxo-4H-
chromen-2-yl)methyl]pentane-1,1,5,5-tetracarboxylate (6c, Dia-
stereomer I): 1H NMR (300 MHz, CDCl3): δ = 0.95, 1.13, 1.25, 1.26
(4 × t, J = 7.1 Hz, 12 H, CO2CH2CH3), 1.89–1.97 (m, 2 H, γ-H), 2.31–
2.38 (m, 1 H, -H), 2.73 (dd, J = 14.9, 8.6 Hz, 1 H, α-H), 3.01 (dd, J =
14.9, 4.5 Hz, 1 H, α-H), 3.34 (d, J = 5.3 Hz, 1 H, 1′′-H), 3.47–3.54 (m,
1 H, δ-H), 3.55 (d, J = 10.6 Hz, 1 H, 2′′-H), 3.79 (s, 3 H, OCH3), 3.87
(q, J = 7.1 Hz, 2 H, CO2CH2CH3), 4.07–4.29 (m, 6 H, CO2CH2CH3), 6.17
(s, 1 H, 3-H), 6.84 (d, J = 8.7 Hz, 2 H, 3′-H, 5′-H), 7.15 (d, J = 8.7 Hz,
2 H, 2′-H, 6′-H), 7.35–7.41 (m, 2 H, 6-H, 8-H), 7.64 (ddd, J = 8.4, 7.3,
1.8 Hz, 1 H, 7-H), 8.17 (dd, J = 7.8, 1.8 Hz, 1 H, 5-H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 13.71, 13.77, 13.90, 14.09 (CO2CH2CH3), 34.3
(C-), 35.1, 35.2 (C-α, C-γ), 42.6 (C-δ), 54.0 (C-1′′), 55.2 (OCH3), 59.1
(C-2′′), 61.2, 61.45, 61.46, 61.7 (CO2CH2CH3), 111.7 (C-3), 113.9 (C-3′,
C-5′), 118.0 (C-8), 123.7 (C-4a), 125.1 (C-6), 125.6 (C-5), 129.7 (C-2′,
C-6′), 131.0 (C-1′), 133.5 (C-7), 156.4 (C-8a), 158.8 (C-4′), 167.0 (C-2),
167.6, 168.0, 168.14, 168.16 (CO2CH2CH3), 178.0 (C-4) ppm. ESI-MS:
m/z (%) = 625 (100) [M + H]+, 626 (37) [M + 2H]+. ESI-HRMS: calcd.
for C34H41O11 [M + H]+ 625.2643; found 625.2628.
Tetraethyl rel-(2S,4S)-2-(4-Methoxyphenyl)-4-[(4-oxo-4H-
chromen-2-yl)methyl]pentane-1,1,5,5-tetracarboxylate (6c, Dia-
stereomer II): 1H NMR (300 MHz, CDCl3): δ = 0.90 (t, J = 7.1 Hz, 3
H, CO2CH2CH3), 1.23–1.30 (m, 6 H, CO2CH2CH3), 1.34 (t, J = 7.1 Hz,
3 H, CO2CH2CH3), 1.66–1.74 (m, 2 H, γ-H), 2.31–2.38 (m, 1 H, -H),
2.57 (dd, J = 14.4, 10.5 Hz, 1 H, α-H), 2.83 (dd, J = 14.4, 3.7 Hz, 1 H,
α-H), 3.28–3.37 (m, 1 H, δ-H), 3.45 (d, J = 10.9 Hz, 1 H, 2′′-H), 3.62
(s, 3 H, OCH3), 3.74 (d, J = 3.9 Hz, 1 H, 1′′-H), 3.74–4.30 (m, 8 H,
CO2CH2CH3), 6.04 (s, 1 H, 3-H), 6.50 (d, J = 8.6 Hz, 2 H, 3′-H, 5′-H),
6.91 (d, J = 8.6 Hz, 2 H, 2′-H, 6′-H), 7.12–7.14 (m, 1 H, 8-H), 7.35–
7.41 (m, 1 H, 6-H), 7.58–7.64 (m, 1 H, 7-H), 8.15–8.18 (m, 1 H, 5-
H) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.71, 13.77, 13.90, 14.09
(CO2CH2CH3), 34.1 (C-), 35.3 (C-γ), 36.6 (C-α), 42.8 (C-δ), 52.5
(C-1 ′ ′ ) , 55.0 (OCH3) , 58.6 (C-2 ′ ′ ) , 61 .1 , 61.52, 61.58, 61.62
(CO2CH2CH3), 111.6 (C-3), 113.7 (C-3′, C-5′), 117.9 (C-8), 123.5 (C-4a),
124.9 (C-6), 125.5 (C-5), 129.1 (C-2′, C-6′), 131.1 (C-1′), 133.3 (C-7),
156.3 (C-8a), 158.5 (C-4′), 167.1 (C-2), 167.5, 168.14, 168.16, 168.7
(CO2CH2CH3), 178.0 (C-4) ppm. ESI-MS: m/z (%) = 625 (100) [M +
H]+, 626 (37) [M + 2H]+. ESI-HRMS: calcd. for C34H41O11 [M + H]+
625.2643; found 625.2628.
Ethyl (E)-2-Cyano-5-(4-methoxyphenyl)-3-[(4-oxo-4H-chromen-
2-yl)methyl]pent-4-enoate (5d): DBU (0.1 mmol, 14.9 μL) was
added to a solution of chromone 1c (0.1 mmol, 30 mg) in ethyl
cyanoacetate (0.5 mL). The reaction mixture was stirred at room
temperature for 24 h and then poured into water (5 mL), and the
pH was adjusted to 4 with dilute HCl. The aqueous mixture was
extracted with dichloromethane (3 × 5 mL), dried with anhydrous
sodium sulfate, and concentrated under reduced pressure. The
crude residue was purified by preparative TLC with hexane/ethyl
acetate (9:7) as the eluent. The desired product 5d was obtained as
an inseparable mixture of two diastereomers: yield 29.2 mg (70 %).
Ethyl rel-(2R,3S)-(E)-2-Cyano-5-(4-methoxyphenyl)-3-[(4-oxo-4H-
chromen-2-yl)methyl]pent-4-enoate (5d, Diastereomer I): 1H
NMR (500 MHz, CDCl3): δ = 1.23 (t, J = 7.1 Hz, 3 H, CO2CH2CH3),
2.99 (d, J = 7.7 Hz, 2 H, α-H), 3.48–3.54 (m, 1 H, -H), 3.74 (d, J =
4.2 Hz, 1 H, 1′′-H), 3.80 (s, 3 H, OCH3), 4.23 (q, J = 7.1 Hz, 2 H,
CO2CH2CH3), 6.00 (dd, J = 15.7, 9.4 Hz, 1 H, γ-H), 6.27 (s, 1 H, 3-H),
6.50 (d, J = 15.7 Hz, 1 H, δ-H), 6.83 (d, J = 8.8 Hz, 2 H, 3′-H, 5′-H),
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7.26 (d, J = 8.8 Hz, 2 H, 2′-H, 6′-H), 7.37–7.42 (m, 1 H, 6-H), 7.46 (d,
J = 8.0 Hz, 1 H, 8-H), 7.67 (ddd, J = 8.0, 7.0, 1.5 Hz, 1 H, 7-H), 8.17
(dd, J = 8.1, 1.5 Hz, 1 H, 5-H) ppm. 13C NMR (125 MHz, CDCl3): δ =
14.1 (CO2CH2CH3), 38.2 (C-α), 41.94 (C-), 42.8 (C-1′′), 55.3 (OCH3),
63.2 (CO2CH2CH3), 111.9 (C-3), 114.07 (C-3′, C-5′), 114.6 (CN), 117.88
(C-8), 121.7 (C-γ), 123.69 (C-4a), 125.4 (C-6), 125.83 (C-5), 127.9
(C-2′, C-6′), 128.4 (C-1′), 133.9 (C-7), 134.9 (C-δ), 156.39 (C-8a), 159.8
(C-4′), 164.6 (CO2CH2CH3), 164.72 (C-2), 177.88 (C-4) ppm. ESI-MS:
m/z (%) = 418 (100) [M + H]+, 419 (25) [M + 2H]+. ESI-HRMS: calcd.
for C25H24NO5 [M + H]+ 418.1649; found 418.1633.
Ethyl rel-(2S,3S)-(E)-2-Cyano-5-(4-methoxyphenyl)-3-[(4-oxo-4H-
chromen-2-yl)methyl]pent-4-enoate (5d, Diastereomer II): 1H
NMR (500 MHz, CDCl3): δ = 1.28 (t, J = 7.2 Hz, 3 H, CO2CH2CH3),
2.92 (dd, J = 14.4, 9.2 Hz, 1 H, α-H), 3.09 (dd, J = 14.4, 5.4 Hz, 1 H,
α-H), 3.48–3.54 (m, 1 H, -H), 3.70 (d, J = 5.5 Hz, 1 H, 1′′-H), 3.79 (s,
3 H, OCH3), 4.19–4.23 (m, 2 H, CO2CH2CH3), 5.95 (dd, J = 15.7, 9.1 Hz,
1 H, γ-H), 6.24 (s, 1 H, 3-H), 6.50 (d, J = 15.7 Hz, 1 H, δ-H), 6.81 (d,
J = 8.7 Hz, 2 H, 3′-H, 5′-H), 7.22 (d, J = 8.7 Hz, 2 H, 2′-H, 6′-H), 7.37–
7.42 (m, 1 H, 6-H), 7.44 (d, J = 7.8 Hz, 1 H, 8-H), 7.64–7.67 (m, 1 H,
7-H), 8.15 (dd, J = 8.6, 1.4 Hz, 1 H, 5-H) ppm. 13C NMR (125 MHz,
CDCl3): δ = 14.0 (CO2CH2CH3), 37.1 (C-α), 41.86 (C-), 43.0 (C-1′′),
55.3 (OCH3), 63.3 (CO2CH2CH3), 112.0 (C-3), 114.08 (C-3′, C-5′), 115.0
(CN), 117.86 (C-8), 122.8 (C-γ), 123.66 (C-4a), 125.3 (C-6), 125.77
(C-5), 127.8 (C-2′, C-6′), 128.3 (C-1′), 133.8 (C-7), 134.3 (C-δ), 156.36
(C-8a), 159.8 (C-4′), 164.71 (C-2), 165.0 (CO2CH2CH3), 177.92 (C-4)
ppm. ESI-MS: m/z (%) = 418 (100) [M + H]+, 419 (25) [M + 2H]+. ESI-
HRMS: calcd. for C25H24NO5 [M + H]+ 418.1649; found 418.1633.
General Procedure for the Synthesis of (Z)-1-(2-Hydroxy-
phenyl)-2-[(E)-4-styrylpyrrolidin-2-yliden]ethan-1-ones 8a–8d:
Zinc (powder, 2.055 mmol, 134 mg) and NH4OAc (2.055 mmol,
158 mg) were added to a solution of the appropriate -(nitro-
methyl)chromone 2a–2d (0.137 mmol) in MeOH/CH2Cl2 (1:1, 5 mL).
The slurry was stirred at room temperature for 30 min. The solid
was removed by filtration, and the solvent was evaporated under
reduced pressure. The crude product was purified by preparative
TLC with dichloromethane as eluent to give 8a–8d in good yields.
(Z)-1-(2-Hydroxyphenyl)-2-[(E)-4-styrylpyrrolidin-2-yliden]-
ethan-1-one (8a): Yield 29.7 mg (71 %), yellow solid, m.p. 128–
130 °C. 1H NMR (300 MHz, CDCl3): δ = 2.73 (dd, J = 16.8, 7.8 Hz, 1
H, 5′-H), 3.00 (dd, J = 16.8, 7.8 Hz, 1 H, 5′-H), 3.26 (sext, J = 7.8 Hz,
1 H, 4′-H), 3.54 (dd, J = 10.9, 7.8 Hz, 1 H, 3′-H), 3.89 (ddd, J = 10.9,
7.8, 1.2 Hz, 1 H, 3′-H), 5.84 (s, 1 H, 2-H), 6.20 (dd, J = 15.8, 7.8 Hz, 1
H, α-H), 6.52 (d, J = 15.8 Hz, 1 H, -H), 6.80 (ddd, J = 8.1, 7.2, 1.2 Hz,
1 H, 5′′′-H), 6.92 (dd, J = 8.3, 1.2 Hz, 1 H, 3′′′-H), 7.22–7.27 (m, 1 H,
4′′-H), 7.30–7.38 (m, 5 H, 2′′-H, 3′′-H, 5′′-H, 6′′-H, 4′′′-H), 7.64 (dd, J =
8.1, 1.7 Hz, 1 H, 6′′′-H), 9.88 (br s, 1 H, NH), 13.76 (s, 1 H, OH) ppm.
13C NMR (75 MHz, CDCl3): δ = 39.3 (C-4′), 40.0 (C-5′), 53.4 (C-3′), 85.5
(C-2), 118.15, 118.17 (C-3′′′, C-5′′′), 120.3 (C-1′′′), 126.2 (C-2′′, C-6′′),
127.73, 127.77 (C-4′′, C-6′′′), 128.7 (C-3′′, C-5′′), 129.2 (C-α), 131.7 (C-
), 133.5 (C-4′′′), 136.5 (C-1′′), 162.4 (C-2′′′), 168.7 (C-1′), 191.2 (C-
1) ppm. ESI-HRMS: calcd. for C20H20NO2 [M + H]+ 306.1494; found
306.1490.
(Z)-2-[(E)-(4-Chlorostyryl)pyrrolidin-2-ylidene]-1-(2-hydroxy-
phenyl)ethan-1-one (8b): Yield 30.7 mg (66 %), yellow solid, m.p.
147–148 °C. 1H NMR (300 MHz, CDCl3): δ = 2.70 (dd, J = 16.8, 7.7 Hz,
1 H, 5′-H), 2.98 (dd, J = 16.8, 7.7 Hz, 1 H, 5′-H), 3.23 (sext, J = 7.7 Hz,
1 H, 4′-H), 3.52 (dd, J = 10.9, 7.7 Hz, 1 H, 3′-H), 3.87 (dd, J = 10.9,
7.7 Hz, 1 H, 3′-H), 5.83 (s, 1 H, 2-H), 6.16 (dd, J = 15.8, 7.7 Hz, 1 H,
α-H), 6.46 (dd, J = 15.8, 0.9 Hz, 1 H, -H), 6.80 (ddd, J = 8.2, 7.2,
1.2 Hz, 1 H, 5′′′-H), 6.92 (dd, J = 8.5, 1.2 Hz, 1 H, 3′′′-H), 7.32 (ddd,
J = 8.5, 7.2, 1.7 Hz, 1 H, 4′′′-H), 7.63 (dd, J = 8.2, 1.7 Hz, 1 H, 6′′′-H),
9.86 (br s, 1 H, NH), 13.75 (s, 1 H, OH) ppm; the signals of 2′′-H, 3′′-
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H, 5′′-H, and 6′′-H were overlapped with the solvent signal. 13C NMR
(75 MHz, CDCl3): δ = 39.2 (C-4′), 39.9 (C-5′), 53.3 (C-3′), 85.6 (C-2),
118.17, 118.18 (C-3′′′, C-5′′′), 120.3 (C-1′′′), 127.4 (C-2′′, C-6′′), 127.7
(C-6′′′), 128.8 (C-3′′, C-5′′), 129.9 (C-α), 130.5 (C-), 133.4 (C-4′′), 133.5
(C-4′′′), 135.0 (C-1′′), 162.4 (C-2′′′), 168.5 (C-1′), 191.2 (C-1) ppm. ESI-
HRMS: calcd. for C20H1935ClNO2 [M + H]+ 340.1104; found 340.1095;
calcd. for C20H1937ClNO2 [M + H]+ 342.1075; found 342.1062.
(Z)-1-(2-Hydroxyphenyl)-2-[(E)-(4-methoxystyryl)pyrrolidin-2-yl-
iden]ethan-1-one (8c): Yield 34.5 mg (75 %), yellow solid, m.p.
161–163 °C. 1H NMR (300 MHz, CDCl3): δ = 2.71 (dd, J = 16.8, 7.8 Hz,
1 H, 5′-H), 2.98 (dd, J = 16.8, 7.8 Hz, 1 H, 5′-H), 3.23 (sext, J = 7.8 Hz,
1 H, 4′-H), 3.53 (dd, J = 10.9, 7.8 Hz, 1 H, 3′-H), 3.81 (s, 3 H, OCH3),
3.87 (ddd, J = 10.9, 7.8, 1.1 Hz, 1 H, 3′-H), 5.83 (s, 1 H, 2-H), 6.05 (dd,
J = 15.7, 7.8 Hz, 1 H, α-H), 6.46 (d, J = 15.7 Hz, 1 H, -H), 6.80 (ddd,
J = 8.1, 7.2, 1.2 Hz, 1 H, 5′′′-H), 6.86 (d, J = 8.7 Hz, 2 H, 3′′-H, 5′′-H),
6.92 (dd, J = 8.3, 1.2 Hz, 1 H, 3′′′-H), 7.30 (d, J = 8.7 Hz, 2 H, 2′′-H,
6′′-H), 7.32 (ddd, J = 8.3, 7.2, 1.6 Hz, 1 H, 4′′′-H), 7.63 (dd, J = 8.1,
1.6 Hz, 1 H, 6′′′-H), 9.87 (b. s, 1 H, NH), 13.78 (s, 1 H, OH) ppm. 13C
NMR (75 MHz, CDCl3): δ = 39.4 (C-4′), 40.1 (C-5′), 53.6 (C-3′), 55.3
(OCH3), 85.5 (C-2), 114.1 (C-3′′, C-5′′), 118.13, 118.16 (C-3′′′, C-5′′′),
120.3 (C-1′′′), 127.0 (C-α), 127.4 (C-2′′, C-6′′), 127.7 (C-6′′′), 129.3
(C-1′′), 131.1 (C-), 133.5 (C-4′′′), 159.3 (C-4′′), 162.4 (C-2′′′), 168.8 (C-
1′), 191.1 (C-1) ppm. ESI-HRMS: calcd. for C21H22NO3 [M + H]+
336.1600; found 336.1598.
(Z)-1-(2-Hydroxyphenyl)-2-[(E)-(4-methylstyryl)pyrrolidin-2-yl-
iden]ethan-1-one (8d): Yield 28.9 mg (66 %), yellow solid, m.p.
161–162 °C. 1H NMR (300 MHz, CDCl3): δ = 2.34 (s, 3 H, CH3), 2.72
(dd, J = 16.8, 7.9 Hz, 1 H, 5′-H), 2.99 (dd, J = 16.8, 7.9 Hz, 1 H, 5′-H),
3.25 (sext, J = 7.9 Hz, 1 H, 4′-H), 3.53 (dd, J = 11.0, 7.9 Hz, 1 H, 3′-
H), 3.88 (ddd, J = 11.0, 7.9, 0.9 Hz, 1 H, 3′-H), 5.83 (s, 1 H, 2-H), 6.14
(dd, J = 15.7, 7.9 Hz, 1 H, α-H), 6.49 (d, J = 15.7 Hz, 1 H, -H), 6.78
(ddd, J = 8.0, 7.2, 1.2 Hz, 1 H, 5′′′-H), 6.92 (dd, J = 8.4, 1.2 Hz, 1 H,
3′′′-H), 7.13 (d, J = 8.0 Hz, 2 H, 3′′-H, 5′′-H), 7.26 (d, J = 8.0 Hz, 1 H,
2′′-H, 6′′-H), 7.32 (ddd, J = 8.4, 7.2, 1.7 Hz, 1 H, 4′′′-H), 7.63 (dd, J =
8.0, 1.7 Hz, 1 H, 6′′′-H), 9.88 (br s, 1 H, NH), 13.77 (br s, 1 H, OH)
ppm. 13C NMR (75 MHz, CDCl3): δ = 21.2 (CH3), 39.3 (C-4′), 40.1 (C-
5′), 53.5 (C-3′), 85.5 (C-2), 118.13, 118.17 (C-3′′′, C-5′′′), 120.3 (C-1′′′),
126.1 (C-2′′, C-6′′), 127.7 (C-6′′′), 128.1 (C-α), 129.4 (C-3′′, C-5′′), 131.6
(C-), 133.5 (C-4′′′), 133.7 (C-1′′), 137.6 (C-4′′), 162.4 (C-2′′′), 168.8
(C-1′), 191.2 (C-1) ppm. ESI-HRMS: calcd. for C21H22NO2 [M + H]+
320.1651; found 320.1642.
(Z)-1-(2-Hydroxyphenyl)-2-[(E)-(4-methoxystyryl)pyrrolidin-2-yl-
iden]ethan-1-one (8c) and (E)-5-[2-(2-Hydroxyphenyl)-2-
oxoethyl]-3-(4-methoxystyryl)-3,4-dihydro-2H-pyrrole 1-Oxide
(7): Compounds 8c and 7 (I and II) were obtained if zinc (powder,
5 equiv.) and NH4OAc (5 equiv.) or Sn (5 equiv.) and HCl (5 equiv.)
were employed in the reduction of the nitro group of 2c. Yield 25–
35 %, yellow solid. 1H NMR (500 MHz, CDCl3): I: δ = 2.79 (dd, J =
16.9, 7.1 Hz, 1 H, 5′-H), 3.07 (dd, J = 16.9, 8.5 Hz, 1 H, 5′-H), 3.37–
3.43 (m, 1 H, 4′-H), 3.81 (s, 3 H, OCH3), 3.89 (dd, J = 12.4, 7.2 Hz, 1
H, 3′-H), 4.10–4.17 (m, 1 H, 3′-H), 5.45 (s, 1 H, 2-H), 6.03 (dd, J = 15.7,
8.4 Hz, 1 H, α-H), 6.45 (d, J = 15.7 Hz, 1 H, -H), 6.80 (ddd, J = 8.1,
7.2, 1.2 Hz, 1 H, 5′′′-H), 6.87 (d, J = 8.8 Hz, 2 H, 3′′-H,5′′-H), 6.91 (dd,
J = 8.3, 1.2 Hz, 1 H, 3′′′-H), 7.25–7.32 (m, 1 H, 4′′′-H), 7.30 (d, J =
8.8 Hz, 2 H, 2′′-H, 6′′-H), 7.57 (dd, J = 8.1, 1.6 Hz, 1 H, 6′′′-H), 11.90
(s, 1 H, 2′-OH), 15.73 (br s, 1 H, N-OH) ppm. 13C NMR (125 MHz,
CDCl3): I: δ = 36.8 (C-4′), 40.2 (C-5′), 55.3 (OCH3), 61.9 (C-3′), 84.1 (C-
2), 114.13 (C-3′′, C-5′′), 118.4 (C-3′′′), 118.7 (C-5′′′), 119.9 (C-1′′′),
125.7 (C-α), 127.54 (C-2′′, C-6′′), 128.0 (C-6′′′), 128.8 (C-1′′), 131.8 (C-
), 133.1 (C-4′′′), 155.2 (C-1′), 159.5 (C-4′′), 160.6 (C-2′′′), 180.7 (C-1)
ppm. 1H NMR (500 MHz, CDCl3): II: δ = 2.71–2.76 (m, 1 H, 5′-H),
3.08–3.13 (m, 1 H, 5′-H), 3.37–3.43 (m, 1 H, 4′-H), 3.82 (s, 3 H, OCH3),
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3.95–4.00 (m, 1 H, 3′-H), 4.23–4.27 (m, 1 H, 3′-H), 4.25 (s, 2 H, 2-H),
6.02 (dd, J = 15.7, 8.9 Hz, 1 H, α-H), 6.42 (d, J = 15.7 Hz, 1 H, -H),
6.85 (d, J = 8.7 Hz, 2 H, 3′′-H, 5′′-H), 6.96 (ddd, J = 8.1, 7.2, 1.1 Hz,
1 H, 5′′′-H), 7.00 (dd, J = 8.5, 1.1 Hz, 1 H, 3′′′-H), 7.26 (d, J = 8.7 Hz,
2 H, 2′′-H, 6′′-H), 7.52 (ddd, J = 8.5, 7.2, 1.6 Hz, 1 H, 4′′′-H), 7.91 (dd,
J = 8.1, 1.6 Hz, 1 H, 6′′′-H), 11.83 (s, 1 H, 2′-OH) ppm. 13C NMR
(125 MHz, CDCl3): II: δ = 34.9 (C-4′), 37.0 (C-2), 38.6 (C-5′), 55.3
(OCH3), 67.2 (C-3′), 114.08 (C-3′′, C-5′′), 118.6 (C-3′′′), 118.9 (C-1′′′),
119.6 (C-5′′′), 126.6 (C-α), 127.48 (C-2′′, C-6′′), 128.9 (C-1′′), 130.4 (C-
6′′′), 131.3 (C-), 137.3 (C-4′′′), 140.5 (C-1′), 159.4 (C-4′′), 162.6
(C-2′′′), 200.1 (C-1) ppm. ESI-HRMS: calcd. for C21H22NO4 [M + H]+
352.1549; found 352.1547.
(E)-2-[2-(3,5-Dimethyl-1H-pyrazol-4-yl)-4-(4-methoxy-
phenyl)but-3-en-1-yl]-4H-chromen-4-one (10): Hydrazine hydrate
(50–60 %, 0.270 mmol, 8.4 μL) was added to a solution of derivative
5b (0.135 mmol, 54.8 mg) in ethanol (4 mL). The mixture was stirred
for 1 h at room temperature. The solvent was evaporated to dry-
ness, and the residue was purified by preparative TLC with dichloro-
methane/ethyl acetate (1:2) as the eluent. Yield 43.2 mg (80 %),
white solid, m.p. 93–96 °C. 1H NMR (300 MHz, CDCl3): δ = 2.21 (s, 6
H, 3′′-CH3, 5′′-CH3), 2.98 (dd, J = 14.1. 9.4 Hz, 1 H, H-α), 3.17 (dd, J =
14.1, 6.8 Hz, 1 H, α-H), 3.80 (s, 3 H, 4′-OCH3), 3.99–4.06 (m, 1 H, -
H), 6.10 (s, 1 H, 3-H), 6.22–6.36 (m, 2 H, γ-H, δ-H), 6.83 (d, J = 8.7 Hz,
2 H, 3′-H, 5′-H), 7.26 (d, J = 8.7 Hz, 2 H, 2′-H, 6′-H), 7.39–7.42 (m, 2
H, 6-H, 8-H), 7.64 (ddd, J = 8.6. 7.1, 1.6 Hz, 1 H, 7-H), 8.15 (dd, J =
7.9, 1.6 Hz, 1 H, 5-H) ppm. 13C NMR (75 MHz, CDCl3): δ = 11.7
(3′′-CH3, 5′′-CH3), 36.2 (C-), 39.5 (C-α), 55.3 (OCH3), 111.1 (C-3),
114.0 (C-3′, C-5′), 114.7 (C-4′′), 117.7 (C-8), 123.6 (C-4a), 125.1 (C-6),
125.8 (C-5), 127.3 (C-2′,6′), 128.2, 129.5 (C-γ, C-δ), 129.6 (C-1′), 133.6
(C-7), 142.2 (C-3′′, C-5′′), 156.3 (C-8a), 159.1 (C-4′), 167.4 (C-2), 178.1




hydrate (50–60 %, 0.677 mmol, 0.02 mL) was added to a solution of
derivative 5b (0.135 mmol, 54.8 mg) in ethanol (4 mL). The mixture
was stirred for 1 h at room temperature. The solvent was evapo-
rated to dryness, and the residue was purified by preparative TLC
with dichloromethane/ethyl acetate (1:1) as the eluent. Yield
42.1 mg (75 %), white solid, m.p. 229–231 °C. 1H NMR [500 MHz,
CDCl3 + trifluoroacetic acid (TFA)]: δ = 2.49 (s, 6 H, 3′′′-CH3, 5′′-CH3),
3.31 (dd, J = 14.8, 7.1 Hz, 1 H, α-H), 3.60 (dd, J = 14.8, 8.6 Hz, 1 H,
α-H), 3.86 (s, 3 H, OCH3), 3.92–4.00 (m, 1 H, -H), 6.16 (dd, J = 15.9,
6.8 Hz, 1 H, γ-H), 6.35 (d, J = 15.9 Hz, 1 H, δ-H), 6.75 (s, 1 H, 4′-H),
6.89 (d, J = 8.8 Hz, 2 H, 3′′′-H, 5′′′-H), 7.03–7.11 (m, 2 H, 4-H, 6-H),
7.25 (d, J = 8.8 Hz, 2 H, 2′′′-H, 6′′′-H), 7.45 (ddd, J = 8.3, 7.8, 1.5 Hz,
1 H, 5-H), 7.62 (dd, J = 7.9, 1.5 Hz, 1 H) ppm. 13C NMR (125 MHz,
CDCl3 + TFA): δ = 10.3 (3′′′-CH3, 5′′-CH3), 30.0 (C-α), 37.8 (C-), 55.7
(4′′′-OCH3), 103.6 (C-4′), 111.3 (C-2), 114.5 (C-3′′′, C-5′′′), 117.2 (C-6),
119.2 (C-4′′), 121.6 (C-4), 123.8 (C-γ), 127.7 (C-2′′′, C-6′′′), 128.3 (C-
3), 128.7 (C-1′′′), 132.6 (C-δ), 133.7 (C-5), 143.8 (C-3′′, C-5′′), 145.8 (C-
3′), 146.0 (C-5′), 154.1 (C-1), 159.1 (C-4′′′) ppm. ESI-HRMS: calcd. for
C25H27N4O2 [M + H]+ 415.2134; found 415.2132.
(E)-{4′-(4-Methoxystyryl)-3′,4′,5′,6′-tetrahydrospiro[chromene-
2,2′-pyran]-5′-yl}methanol (12): LiAlH4 [2.4 M in tetrahydrofuran
(THF), 0.501 mmol, 0.25 mL] was added dropwise to a stirred solu-
tion of derivative 5c (0.083 mmol, 38.8 mg) in dry THF (3 mL) under
a nitrogen atmosphere. After 1 h, the mixture was poured into wa-
ter (10 mL), and the pH was adjusted to 6–7 with dilute HCl. The
aqueous mixture was extracted with dichloromethane (3 × 10 mL),
dried with anhydrous sodium sulfate, and concentrated under re-
duced pressure. The crude residue was purified by preparative TLC
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with hexane/ethyl acetate (9:7) as the eluent. Yield 3 mg (10 %),
colorless oil. 1H NMR (500 MHz, CDCl3): δ = 1.75 (dd, J = 13.5,
12.3 Hz, 1 H, 3′-H), 1.81–1.88 (m, 1 H, 5′-H), 2.22 (dd, J = 13.5, 4.1 Hz,
1 H, 3′-H), 2.89–2.97 (m, 1 H, 4′-H), 3.57–3.60 (m, 1 H, CH2OH), 3.78–
3.83 (m, 2 H, 6′-H, CH2OH), 3.81 (s, 3 H, OCH3), 3.90 (t, J = 11.4 Hz,
1 H, 6′-H), 5.74 (d, J = 9.6 Hz, 1 H, 3-H), 5.91 (dd, J = 15.8, 9.1 Hz, 1
H, α-H), 6.51 (d, J = 15.8 Hz, 1 H, -H), 6.69 (d, J = 9.6 Hz, 1 H, 4-H),
6.86 (d, J = 8.7 Hz, 2 H, 3′′-H, 5′′-H), 6.97 (dt, J = 7.4, 1.1 Hz, 1 H, 6-
H), 7.03 (d, J = 8.0 Hz, 1 H, 8-H), 7.15 (dd, J = 7.4, 1.6 Hz, 1 H, 5-H),
7.23 (ddd, J = 8.0, 7.4, 1.6 Hz, 1 H, 7-H), 7.31 (d, J = 8.7 Hz, 2 H, 2′′-
H, 6′′-H) ppm. 13C NMR (125 MHz, CDCl3): δ = 36.9 (C-4′), 41.4 (C-3′
), 42.2 (C-5′), 55.3 (OCH3), 63.1 (CH2OH), 63.6 (C-6′), 95.4 (C-2′), 114.0
(C-3′′,5′′), 116.5 (C-8), 121.0 (C-4a), 121.6 (C-6), 124.7 (C-3), 126.5 (C-
4), 127.1 (C-5), 127.3 (C-2′′, C-6′′), 129.3 (C-7), 129.68 (C-α), 129.74
(C-1′′), 130.8 (C-), 151.2 (C-8a), 159.1 (C-4′′) ppm. ESI-HRMS: calcd.
for C23H25O4 [M + H]+ 365.1753; found 365.1742.
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